T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$1.31B |
| 2 |
Home Depot
HD
|
+$1.07B |
| 3 |
Alibaba
BABA
|
+$1.06B |
| 4 |
Yum! Brands
YUM
|
+$887M |
| 5 |
Honeywell
HON
|
+$860M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
N
Netsuite Inc
N
|
+$1.59B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.33B |
| 3 |
Danaher
DHR
|
+$1.13B |
| 4 |
HBI
Hanesbrands
HBI
|
+$1.06B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$845M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.86% |
| 2 | Healthcare | 16.8% |
| 3 | Consumer Discretionary | 15.02% |
| 4 | Technology | 13.29% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Bristol-Myers Squibb
BMY
$130B
| $2.16B | 0.43% |
37,016,731
-8,123,043
| -18% | -$444M |
|
52
Humana
HUM
$44.8B
| $2.07B | 0.41% |
10,163,639
-3,089,978
| -23% | -$589M |
|
53
Johnson & Johnson
JNJ
$626B
| $2.04B | 0.4% |
17,692,372
+394,814
| +2% | +$45.6M |
|
54
Verizon
VZ
$196B
| $1.99B | 0.39% |
37,233,645
+7,267,533
| +24% | +$363M |
|
55
Johnson Controls International
JCI
$93.7B
| $1.98B | 0.39% |
48,090,707
-4,635,922
| -9% | -$203M |
|
56
Elevance Health
ELV
$84.7B
| $1.98B | 0.39% |
13,777,744
-1,181,496
| -8% | -$158M |
|
|
AGN
57
DELISTED
Allergan plc
AGN
| $1.95B | 0.39% |
9,299,129
-3,433,124
| -27% | -$711M |
|
58
MGM Resorts International
MGM
$11.1B
| $1.95B | 0.39% |
67,717,814
-11,761,557
| -15% | -$326M |
|
59
Cisco
CSCO
$475B
| $1.94B | 0.39% |
64,247,137
-5,613,831
| -8% | -$171M |
|
60
Dollar General
DG
$26.5B
| $1.94B | 0.38% |
26,169,340
+8,835,777
| +51% | +$645M |
|
61
PepsiCo
PEP
$189B
| $1.94B | 0.38% |
18,496,842
-3,145,960
| -15% | -$329M |
|
62
Fortive
FTV
$18.6B
| $1.92B | 0.38% |
56,888,536
+1,117,650
| +2% | +$37M |
|
63
Willis Towers Watson
WTW
$31.8B
| $1.9B | 0.38% |
15,574,068
-789,688
| -5% | -$98.5M |
|
|
CELG
64
DELISTED
Celgene Corp
CELG
| $1.89B | 0.38% |
16,346,024
-1,661,133
| -9% | -$185M |
|
65
Marriott International
MAR
$91.1B
| $1.89B | 0.38% |
22,844,024
+411,533
| +2% | +$31M |
|
66
Netflix
NFLX
$311B
| $1.87B | 0.37% |
150,787,150
-48,248,840
| -24% | -$572M |
|
67
Mondelez International
MDLZ
$78.9B
| $1.85B | 0.37% |
41,723,139
+1,858,217
| +5% | +$80.1M |
|
68
Textron
TXT
$15.2B
| $1.83B | 0.36% |
37,716,612
+1,023,406
| +3% | +$44.6M |
|
69
Cigna
CI
$72.4B
| $1.82B | 0.36% |
13,621,678
-274,825
| -2% | -$36M |
|
70
ServiceNow
NOW
$132B
| $1.79B | 0.36% |
120,514,375
-3,536,205
| -3% | -$57.1M |
|
|
RHT
71
DELISTED
Red Hat Inc
RHT
| $1.79B | 0.35% |
25,622,509
+5,377,876
| +27% | +$415M |
|
|
HOLX
72
DELISTED
Hologic
HOLX
| $1.74B | 0.35% |
43,323,814
+2,015,135
| +5% | +$77.8M |
|
73
Qualcomm
QCOM
$171B
| $1.62B | 0.32% |
24,776,918
+6,361,346
| +35% | +$427M |
|
|
FITB
74
Fifth Third Bancorp
FITB
$52.2B
| $1.61B | 0.32% |
59,750,574
+10,913,116
| +22% | +$262M |
|
75
Vertex Pharmaceuticals
VRTX
$134B
| $1.61B | 0.32% |
21,860,325
-1,623,063
| -7% | -$132M |
|
Similar funds
T. Rowe Price Associates's Q4 2016 Portfolio in Review
As of Q4 2016, T. Rowe Price Associates held 2,620 positions worth $504B, up 1.2% from $498B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2016 filing shows 96 new, 950 increased, 1,023 reduced and 72 closed positions. Its largest new stake was Adient: 10,357,941 shares worth $607M. The largest sale was Netsuite Inc, an estimated $1.59B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2016 buy was Adient: 10,357,941 shares worth $607M.
- T. Rowe Price Associates added most to Wells Fargo in Q4 2016, an estimated $1.31B increase.
- T. Rowe Price Associates's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $1.33B.
- T. Rowe Price Associates fully exited Netsuite Inc in Q4 2016, selling an estimated $1.59B.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $504B portfolio in Q4 2016.
- T. Rowe Price Associates opened 96 new positions and closed 72 in Q4 2016.
- T. Rowe Price Associates's portfolio value rose 1.2% quarter-over-quarter to $504B.
Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.